[go: up one dir, main page]

DE60111494D1 - Verfahren zur erhöhung der wachsamkeit durch verabreichung von vomeropherin und vomeropherin emittierende alarmvorricthung - Google Patents

Verfahren zur erhöhung der wachsamkeit durch verabreichung von vomeropherin und vomeropherin emittierende alarmvorricthung

Info

Publication number
DE60111494D1
DE60111494D1 DE60111494T DE60111494T DE60111494D1 DE 60111494 D1 DE60111494 D1 DE 60111494D1 DE 60111494 T DE60111494 T DE 60111494T DE 60111494 T DE60111494 T DE 60111494T DE 60111494 D1 DE60111494 D1 DE 60111494D1
Authority
DE
Germany
Prior art keywords
vomeropherin
increasing
administration
wax therapy
effective alarm
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60111494T
Other languages
English (en)
Other versions
DE60111494T2 (de
Inventor
L Berliner
Louis Monti
L Jennings-White
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pherin Pharmaceuticals Inc
Original Assignee
Pherin Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pherin Pharmaceuticals Inc filed Critical Pherin Pharmaceuticals Inc
Publication of DE60111494D1 publication Critical patent/DE60111494D1/de
Application granted granted Critical
Publication of DE60111494T2 publication Critical patent/DE60111494T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Emergency Alarm Devices (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE60111494T 2000-02-04 2001-02-02 Verfahren zur erhöhung der wachsamkeit durch verabreichung von vomeropherin und vomeropherin emittierende alarmvorricthung Expired - Lifetime DE60111494T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/498,830 US6544971B1 (en) 2000-02-04 2000-02-04 Method of increasing alertness by administration of a vomeropherin, and vomeropherin-emitting alarm devices
US498830 2000-02-04
PCT/US2001/003572 WO2001056577A1 (en) 2000-02-04 2001-02-02 Method of increasing alertness by administration of a vomeropherin, and vomeropherin-emitting alarm devices

Publications (2)

Publication Number Publication Date
DE60111494D1 true DE60111494D1 (de) 2005-07-21
DE60111494T2 DE60111494T2 (de) 2006-05-18

Family

ID=23982680

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60111494T Expired - Lifetime DE60111494T2 (de) 2000-02-04 2001-02-02 Verfahren zur erhöhung der wachsamkeit durch verabreichung von vomeropherin und vomeropherin emittierende alarmvorricthung

Country Status (12)

Country Link
US (1) US6544971B1 (de)
EP (1) EP1251856B1 (de)
JP (1) JP2003523329A (de)
KR (1) KR20020073570A (de)
CN (1) CN1418101A (de)
AT (1) ATE297738T1 (de)
AU (1) AU3329401A (de)
BR (1) BR0108004A (de)
CA (1) CA2397790A1 (de)
DE (1) DE60111494T2 (de)
MX (1) MXPA02007496A (de)
WO (1) WO2001056577A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7283427B1 (en) 2005-12-08 2007-10-16 James Thomas Stevens Machine for waking a sleeper
DE102007022916A1 (de) * 2007-05-14 2008-11-20 Henkel Ag & Co. Kgaa Pheromonhaltige kosmetische Mittel
DE102012009570A1 (de) * 2012-05-09 2013-11-14 Naum Goldstein Komposition für nasale Anwendung
US12269315B2 (en) 2020-08-20 2025-04-08 Denso International America, Inc. Systems and methods for measuring and managing odor brought into rental vehicles
US11760170B2 (en) 2020-08-20 2023-09-19 Denso International America, Inc. Olfaction sensor preservation systems and methods
US11932080B2 (en) 2020-08-20 2024-03-19 Denso International America, Inc. Diagnostic and recirculation control systems and methods
US12251991B2 (en) 2020-08-20 2025-03-18 Denso International America, Inc. Humidity control for olfaction sensors
US12017506B2 (en) 2020-08-20 2024-06-25 Denso International America, Inc. Passenger cabin air control systems and methods
US11828210B2 (en) 2020-08-20 2023-11-28 Denso International America, Inc. Diagnostic systems and methods of vehicles using olfaction
US11881093B2 (en) 2020-08-20 2024-01-23 Denso International America, Inc. Systems and methods for identifying smoking in vehicles
US11760169B2 (en) 2020-08-20 2023-09-19 Denso International America, Inc. Particulate control systems and methods for olfaction sensors
US11636870B2 (en) 2020-08-20 2023-04-25 Denso International America, Inc. Smoking cessation systems and methods
US12377711B2 (en) 2020-08-20 2025-08-05 Denso International America, Inc. Vehicle feature control systems and methods based on smoking
US11813926B2 (en) 2020-08-20 2023-11-14 Denso International America, Inc. Binding agent and olfaction sensor
WO2024254005A1 (en) 2023-06-04 2024-12-12 Vistagen Therapeutics, Inc. 1,3,5(10),16-estratetraen-3-yl acetate for use in improving psychomotor or cognitive performance

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUT74172A (en) 1993-06-15 1996-11-28 Pherin Corp Androstane steroids as neurochemical initilators of change in human hypothalamic function and pharmaceutical compositions containing them
PL177474B1 (pl) 1993-06-15 1999-11-30 Pherin Pharmaceuticals Kompozycja farmaceutyczna do donosowego podawania ludziom zawierająca związek steroidowy oraz związek steroidowy

Also Published As

Publication number Publication date
EP1251856B1 (de) 2005-06-15
CA2397790A1 (en) 2001-08-09
ATE297738T1 (de) 2005-07-15
US6544971B1 (en) 2003-04-08
JP2003523329A (ja) 2003-08-05
CN1418101A (zh) 2003-05-14
WO2001056577A1 (en) 2001-08-09
KR20020073570A (ko) 2002-09-27
AU3329401A (en) 2001-08-14
EP1251856A1 (de) 2002-10-30
BR0108004A (pt) 2004-01-06
MXPA02007496A (es) 2002-12-13
DE60111494T2 (de) 2006-05-18

Similar Documents

Publication Publication Date Title
DE60111494D1 (de) Verfahren zur erhöhung der wachsamkeit durch verabreichung von vomeropherin und vomeropherin emittierende alarmvorricthung
ATE119040T1 (de) Zentrale cholecystokinin-antagonisten zur behandlung von psychiatrischen krankheiten.
ATE232384T1 (de) Zusammensetzungen zur behandlung von nikotinabhängigkeit, enthaltend mecamylamin und bupropion
DE50006156D1 (de) Vorrichtung und verwendung zur steigerung der transdermalen permeation von arzneistoffen
DE60202477D1 (de) Vorrichtung zur verabreichung einer substanz
ATE265213T1 (de) Noribogain zur behandlung von schmerzen und drogenabhängigkeit
ES2123064T3 (es) Uso de melatonina en pequeñas dosis orales como somnifero.
DE60031396D1 (de) Zubereitung zur behandlung von einer neurologischen erkrankung
DK0776202T3 (da) Liposomalt indkapslet taxol, dets fremstilling af dets anvendelse
SE9401406D0 (sv) Pharmaceutical products for curing tumourous diseases and process for preparing same
DE602004005076D1 (de) Coextrudierte sicherheits-dosierform mit einem wirkstoff und einem adversen mittel und herstellungsverfahren dafür
ATE348829T1 (de) Pharmazeutische zusammensetzungen zur behandlung von störungen des zns oder anderen erkrankungen
ATE446751T1 (de) Verwendung von methylnaltrexon zur behandlung von immunsuppression
DE69512685D1 (de) Mittel zur verabreichung von wirksubstanzen an bzw. durch die haut
AR043188A1 (es) Metodos y composiciones para el tratamiento de enfermedades y trastornos asociados con niveles elevados de citoquinas proinflamatorias
HUP0004300A2 (hu) (S)-N-Etil-3-[1-(dimetil-amino)-etil]-N-metil-fenil-karbamátot és antioxidánst tartalmazó gyógyszerkészítmény
BR0110060A (pt) Forma de administração farmacêutica transdérmica ou transmucosa para o tratamento da dependência de nicotina ou para desacostumar fumantes e uso de forma de administração
DE69904922D1 (de) Pharmazeutische zusammensetzung zur behandlung von alkoholabhängigkeit, die opioid antagonisten mit nmda-rezeptorkomplex-modulatoren enthält
DK0636027T3 (da) Angiotensin-II-antogonister mod sygdomme forbundet med forringet neuronal ledningshastighed, især diabetisk neuropati
BRPI0409699A (pt) métodos de indução do efeito diurético, de indução, manutenção ou restauração do efeito diurético de diurético não modificador de adenosina, de manutenção, restauração ou melhoria da função renal em paciente, de indução de diurese, de prevenção do inìcio de deficiência renal em paciente com sobrecarga de fluidos ou chf, de tratamento de paciente que sofre de chf e de melhoria dos resultados globais da saúde, composição farmacêutica e seus usos
ATE216587T1 (de) Verwendung von ginkgo biloba extrakten zur herstellung eines medikaments
DK0391185T3 (da) 1,8-Naphthyridiner
ATE359808T1 (de) Verwendung von sarp-1 zur behandlung und/oder vorbeugung von scleroderma
TR200003502T2 (tr) Bir Piperidin Maddesi P Antagonistini İçeren Mikroemülsiyon Prekonsantratları
DE60206280D1 (de) Verwendung von extrakten aus ginkgo biloba zur herstellung eines medikaments zur behandlung von sarcopenia

Legal Events

Date Code Title Description
8364 No opposition during term of opposition